Gene therapy for refractory angina and cell therapy for heart failure: experience of a Brazilian research group
Gene Ther. 2020 Feb;27(1-2):40-50 DOI: 10.1038/s41434-019-0087-2
Leia mais
Publicações de Imarilde Ines Giusti [8]
GENE THERAPY FOR REFRACTORY ANGINA AND CELL THERAPY FOR HEART FAILURE: EXPERIENCE OF A BRAZILIAN RESEARCH GROUP
Gene Ther. 2020 Feb;27(1-2):40-50 DOI: 10.1038/s41434-019-0087-2
Leia maisVEGF GENE THERAPY COOPERATIVELY RECRUITS MOLECULES FROM THE IMMUNE SYSTEM AND STIMULATES CELL HOMING AND ANGIOGENESIS IN REFRACTORY ANGINA
Cytokine. 2017 Mar;91:44-50. ISSN: 1043-4666 DOI: 10.1016/j.cyto.2016.12.005.
Leia maisHIGH VEGF165 DOSES SAFELY, BUT TRANSIENTLY, IMPROVE MYOCARDIAL PERFUSION IN NO-OPTION ISCHEMIC DISEASE
Human Gene Therapy Methods, 2013;24(5):298-306 – ISSN: 1946-6544 DOI: 10.1089/hgtb.2012.221
Leia maisVEGF GENE THERAPY FOR ANGIOGENESIS IN REFRACTORY ANGINA: CLINICAL TRIAL PHASE I/II
Revista Brasileira de Cirurgia Cardiovascular 2010;25(3):311-321-ISSN: 0102-7638 http://dx.doi.org/10.1590/S0102-76382010000300006
Leia maisVEGF 165 GENE THERAPY FOR PATIENTS WITH REFRACTORY ANGINA: MOBILIZATION OF ENDOTHELIAL PROGENITOR CELLS
Arquivos Brasileiros de Cardiologia, 2013;101(2):149-153 – ISSN: 0066-782x DOI: 10.5935/abc.20130128
Leia maisTERAPIA GÊNICA PARA CARDIOPATIA ISQUÊMICA: REVISÃO DE ENSAIOS CLÍNICOS.
Revista Brasileira de Cirurgia Cardiovascular 2011;26(4):635-646 – ISSN: 0102-7638 DOI: 10.5935/1678-9741.20110056
Leia mais